Article
Comparison of enzymatic and bisulfite conversion of circulating cell-free tumor DNA for DNA methylation analyses
4 Jun 2025
Abstract excerpt
BACKGROUND: Detection of DNA methylation biomarkers in circulating cell-free DNA (cfDNA) has great clinical potential for cancer management, but there is a high need for method optimization and standardization. Bisulfite conversion of DNA is the gold-standard pre-treatment method for DNA methylation analyses, but causes also DNA fragmentation and loss. Enzymatic conversion of DNA represents a promising...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
